BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 26051593)

  • 21. PGE
    Morotti M; Grimm AJ; Hope HC; Arnaud M; Desbuisson M; Rayroux N; Barras D; Masid M; Murgues B; Chap BS; Ongaro M; Rota IA; Ronet C; Minasyan A; Chiffelle J; Lacher SB; Bobisse S; Murgues C; Ghisoni E; Ouchen K; Bou Mjahed R; Benedetti F; Abdellaoui N; Turrini R; Gannon PO; Zaman K; Mathevet P; Lelievre L; Crespo I; Conrad M; Verdeil G; Kandalaft LE; Dagher J; Corria-Osorio J; Doucey MA; Ho PC; Harari A; Vannini N; Böttcher JP; Dangaj Laniti D; Coukos G
    Nature; 2024 May; 629(8011):426-434. PubMed ID: 38658764
    [TBL] [Abstract][Full Text] [Related]  

  • 22. PGE2-EP4 signaling steers cDC2 maturation toward the induction of suppressive T-cell responses.
    Cuenca-Escalona J; Flórez-Grau G; van den Dries K; Cambi A; de Vries IJM
    Eur J Immunol; 2024 Mar; 54(3):e2350770. PubMed ID: 38088451
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Stromal C-type lectin receptor COLEC12 integrates H. pylori, PGE2-EP2/4 axis and innate immunity in gastric diseases.
    Chang LL; Hsu WH; Kao MC; Chou CC; Lin CC; Liu CJ; Weng BC; Kuo FC; Kuo CH; Lin MH; Wang CJ; Lin CH; Wu DC; Huang SK
    Sci Rep; 2018 Feb; 8(1):3821. PubMed ID: 29491476
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prostaglandin E2 is generally required for human dendritic cell migration and exerts its effect via EP2 and EP4 receptors.
    Legler DF; Krause P; Scandella E; Singer E; Groettrup M
    J Immunol; 2006 Jan; 176(2):966-73. PubMed ID: 16393982
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prostaglandin E2 inhibits Tr1 cell differentiation through suppression of c-Maf.
    Hooper KM; Kong W; Ganea D
    PLoS One; 2017; 12(6):e0179184. PubMed ID: 28604806
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Tailored PGE2 Immunomodulation of moDCs by Nano-Encapsulated EP2/EP4 Antagonists.
    Bödder J; Kok LM; Fauerbach JA; Flórez-Grau G; de Vries IJM
    Int J Mol Sci; 2023 Jan; 24(2):. PubMed ID: 36674907
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prostaglandin E2 produced following infection with Theiler's virus promotes the pathogenesis of demyelinating disease.
    Kim SJ; Jin YH; Kim BS
    PLoS One; 2017; 12(4):e0176406. PubMed ID: 28445497
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prostaglandin E2-EP4 signaling promotes immune inflammation through Th1 cell differentiation and Th17 cell expansion.
    Yao C; Sakata D; Esaki Y; Li Y; Matsuoka T; Kuroiwa K; Sugimoto Y; Narumiya S
    Nat Med; 2009 Jun; 15(6):633-40. PubMed ID: 19465928
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Histamine and prostaglandin E up-regulate the production of Th2-attracting chemokines (CCL17 and CCL22) and down-regulate IFN-gamma-induced CXCL10 production by immature human dendritic cells.
    McIlroy A; Caron G; Blanchard S; Frémaux I; Duluc D; Delneste Y; Chevailler A; Jeannin P
    Immunology; 2006 Apr; 117(4):507-16. PubMed ID: 16556265
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Possible involvement of brain prostaglandin E2 and prostanoid EP3 receptors in prostaglandin E2 glycerol ester-induced activation of central sympathetic outflow in the rat.
    Shimizu T; Tanaka K; Nakamura K; Taniuchi K; Yawata T; Higashi Y; Ueba T; Dimitriadis F; Shimizu S; Yokotani K; Saito M
    Neuropharmacology; 2014 Jul; 82():19-27. PubMed ID: 24657150
    [TBL] [Abstract][Full Text] [Related]  

  • 31. PGE2-EP2/EP4 signaling elicits mesoCAR T cell immunosuppression in pancreatic cancer.
    Akbari B; Soltantoyeh T; Shahosseini Z; Jadidi-Niaragh F; Hadjati J; Brown CE; Mirzaei HR
    Front Immunol; 2023; 14():1209572. PubMed ID: 37457723
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Regulatory effects of paeoniflorin-6'-O-benzene sulfonate (CP-25) on dendritic cells maturation and activation via PGE2-EP4 signaling in adjuvant-induced arthritic rats.
    Jia XY; Chang Y; Sun XJ; Wei F; Wu YJ; Dai X; Xu S; Wu HX; Wang C; Yang XZ; Wei W
    Inflammopharmacology; 2019 Oct; 27(5):997-1010. PubMed ID: 30771056
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prostaglandin E2 prevents hyperosmolar-induced human mast cell activation through prostanoid receptors EP2 and EP4.
    Torres-Atencio I; Ainsua-Enrich E; de Mora F; Picado C; Martín M
    PLoS One; 2014; 9(10):e110870. PubMed ID: 25329458
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prostaglandin E2 induces apoptosis in cultured rat microglia.
    Nagano T; Kimura SH; Takemura M
    Brain Res; 2014 Jun; 1568():1-9. PubMed ID: 24845544
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prostaglandin E2 Inhibition of IL-27 Production in Murine Dendritic Cells: A Novel Mechanism That Involves IRF1.
    Hooper KM; Yen JH; Kong W; Rahbari KM; Kuo PC; Gamero AM; Ganea D
    J Immunol; 2017 Feb; 198(4):1521-1530. PubMed ID: 28062696
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inhibitory effect of prostaglandin E(2) on the migration of nasal fibroblasts.
    Shin JM; Park IH; Moon YM; Hong SM; Cho JS; Um JY; Lee HM
    Am J Rhinol Allergy; 2014; 28(3):e120-4. PubMed ID: 24980222
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cell entry of bovine ephemeral fever virus requires activation of Src-JNK-AP1 and PI3K-Akt-NF-κB pathways as well as Cox-2-mediated PGE2 /EP receptor signalling to enhance clathrin-mediated virus endocytosis.
    Cheng CY; Huang WR; Chi PI; Chiu HC; Liu HJ
    Cell Microbiol; 2015 Jul; 17(7):967-87. PubMed ID: 25582828
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Inhibition of inflammatory CD4 T cell activity by murine liver sinusoidal endothelial cells.
    Carambia A; Frenzel C; Bruns OT; Schwinge D; Reimer R; Hohenberg H; Huber S; Tiegs G; Schramm C; Lohse AW; Herkel J
    J Hepatol; 2013 Jan; 58(1):112-8. PubMed ID: 22989568
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mesenchymal stem cell inhibition of T-helper 17 cell- differentiation is triggered by cell-cell contact and mediated by prostaglandin E2 via the EP4 receptor.
    Duffy MM; Pindjakova J; Hanley SA; McCarthy C; Weidhofer GA; Sweeney EM; English K; Shaw G; Murphy JM; Barry FP; Mahon BP; Belton O; Ceredig R; Griffin MD
    Eur J Immunol; 2011 Oct; 41(10):2840-51. PubMed ID: 21710489
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prostaglandin E2 in the Tumor Microenvironment, a Convoluted Affair Mediated by EP Receptors 2 and 4.
    Santiso A; Heinemann A; Kargl J
    Pharmacol Rev; 2024 May; 76(3):388-413. PubMed ID: 38697857
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.